Dolutegravir-induced severe sideroblastic anemia

AIDS. 2024 Jun 1;38(7):1095-1097. doi: 10.1097/QAD.0000000000003855. Epub 2024 May 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Sideroblastic* / chemically induced
  • Anemia, Sideroblastic* / drug therapy
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • HIV Integrase Inhibitors / adverse effects
  • HIV Integrase Inhibitors / therapeutic use
  • Heterocyclic Compounds, 3-Ring* / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Oxazines*
  • Piperazines* / adverse effects
  • Pyridones* / adverse effects

Substances

  • dolutegravir
  • Oxazines
  • Pyridones
  • Heterocyclic Compounds, 3-Ring
  • Piperazines
  • HIV Integrase Inhibitors